0.620
+0.020
(3.33%)
May 24 - Close
NYSEMKT
real-time data -
Disclaimer
Currency in USD
| Range | 0.58 - 0.63 |
| 52 week | 0.25 - 0.88 |
| Open | 0.61 |
| Vol / Avg. | 24,963.00/19,784.00 |
| Mkt cap | 18.19M |
| P/E | 2.64 |
| Div/yield | - |
| EPS | 0.23 |
| Shares | 29.33M |
| Beta | 0.92 |
| Inst. own | 19% |
Events
May 15, 2013
Q3 2013 Tianyin Pharmaceutical Inc Co Earnings Conference Call
May 15, 2013
Q3 2013 Tianyin Pharmaceutical Inc Co Earnings Release
May 8, 2013
Tianyin Pharmaceutical Inc Co Annual Shareholder Meeting
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 8.11% | 8.97% |
| Operating margin | 11.55% | 12.27% |
| EBITD margin | - | 14.02% |
| Return on average assets | 4.89% | 6.42% |
| Return on average equity | 5.43% | 7.48% |
| Employees | 1,200 | - |
| Carbon Disclosure Rating | - | - |
Address
23rd Floor Unionsun Yangkuo Plaza No.2 Block 3, Renmin Road South
CHENGDU, SIC 610041
China
+86-28-86154737 (Phone)
+86-28-85516676 (Fax)
CHENGDU, SIC 610041
China
+86-28-86154737 (Phone)
+86-28-85516676 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company�s indirect wholly owned subsidiary Chengdu Tianyin Pharmaceutical Co., Ltd. (Chengdu Tianyin), it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in the People�s Republic of China. It is manufacturing a range of 56 products, 23 of which are listed in the highly selective National Medical Reimbursement List (NMRL) and seven are listed in the Essential Drug List (EDL) of the People�s Republic of China.
Officers and directors
| Guoqing Jiang | Chairman of the Board, President, Chief Executive Officer | |
| Jiayuan Tong M.D., Ph.D. | Chief Financial Officer, Chief Business & Development Officer, Director | |
| Tao Yang | Chief Operating Officer | |
| Jianping Hou Ph.D. | Independent Director | |
| Bo Tan | Independent Director | |
| Zunjian Zhang Ph.D. | Independent Director |